Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevelamer carbonate versus sevelamer hydrochloride in maintenance hemodialysis
IRCT20141016019554N13Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Mar 2017
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sevelamer carbonate in hyperphosphatemia and chronic kidney disease (CKD) (2 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoints: Blood pH, Serum calcium and 3 more. Started Mar 2017; status: completed.
02
Drugs
sevelamer carbonate
03
Conditions
hyperphosphatemiachronic kidney disease (CKD)
Beyond the preview
Go deeper on IRCT20141016019554N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141016019554N13.